[1]
P. del R. Q. Donoso, R. F. Z. Briones, C. P. M. Castro, D. L. B. Narváez, S. A. Velasco, and S. N. C. Jimenez, “Impact of GLP-1 receptor agonists on cardiovascular risk reduction in patients with obesity without type 2 diabetes mellitus: a systematic review”, Int J Res Med Sci, vol. 14, no. 5, pp. 2051–2057, Apr. 2026.